Tactile Systems Technology Inc TCMD Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Feb 29, 2024 (filed on Feb 29, 2024)

Insider Name:

Burns Kristie

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-243

Price:

$15.25
Feb 29, 2024 (filed on Feb 29, 2024)

Insider Name:

Reuvers Daniel L.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-1,396

Price:

$15.25
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Burns Kristie

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-1,091

Price:

$15.58
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Reuvers Daniel L.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-4,689

Price:

$15.60
Feb 26, 2024 (filed on Feb 27, 2024)

Insider Name:

Reuvers Daniel L.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-6,239

Price:

$15.81
Feb 26, 2024 (filed on Feb 27, 2024)

Insider Name:

Burns Kristie

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-2,015

Price:

$15.91
Feb 24, 2024 (filed on Feb 27, 2024)

Insider Name:

Reuvers Daniel L.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

13,100

Price:

--
Feb 24, 2024 (filed on Feb 27, 2024)

Insider Name:

Reuvers Daniel L.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

44,930

Price:

--
Feb 24, 2024 (filed on Feb 27, 2024)

Insider Name:

Burns Kristie

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

2,776

Price:

--
Feb 24, 2024 (filed on Feb 27, 2024)

Insider Name:

Burns Kristie

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

8,986

Price:

--

Filings by filing date

Feb 29, 2024 (filed on Feb 29, 2024)

Insider Name:

Burns Kristie

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-243

Price:

$15.25
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Burns Kristie

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-1,091

Price:

$15.58
Feb 29, 2024 (filed on Feb 29, 2024)

Insider Name:

Reuvers Daniel L.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-1,396

Price:

$15.25
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Reuvers Daniel L.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-4,689

Price:

$15.60
Feb 26, 2024 (filed on Feb 27, 2024)

Insider Name:

Reuvers Daniel L.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-6,239

Price:

$15.81
Feb 24, 2024 (filed on Feb 27, 2024)

Insider Name:

Reuvers Daniel L.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

13,100

Price:

--
Feb 24, 2024 (filed on Feb 27, 2024)

Insider Name:

Reuvers Daniel L.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

44,930

Price:

--
Feb 23, 2024 (filed on Feb 27, 2024)

Insider Name:

Reuvers Daniel L.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-5,378

Price:

$14.85
Feb 26, 2024 (filed on Feb 27, 2024)

Insider Name:

Burns Kristie

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-2,015

Price:

$15.91
Feb 24, 2024 (filed on Feb 27, 2024)

Insider Name:

Burns Kristie

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

2,776

Price:

--

News

Biz Brief

Sector: Healthcare	Industry: Medical Equipment, Supplies & Distribution

See Regulatory Filings on SEC

Company Contact

Address:	1331 Tyler St NE Ste 200 MINNEAPOLIS MN 55413-1638
Tel:	1-443-2130500
Website:	https://www.tactilemedical.com
IR:	See website

Key People

Daniel L. Reuvers President, Chief Executive Officer, Director	Elaine M. Birkemeyer Chief Financial Officer	Kristie T. Burns Senior Vice President - Marketing and Clinical Affairs
Sherri Ferstler Senior Vice President- Sales

Business Overview

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.

Financial Overview

For the fiscal year ended 31 December 2023, Tactile Systems Technology Inc revenues increased 11% to $274.4M. Net income totaled $28.5M vs. loss of $17.9M. Revenues reflect Lymphedema products segment increase of 14% to $241.7M. Net Income reflects Intangible asset amortization and earn-o decrease of 99% to $76K (expense), Stock-based Compensation in S& M decrease of 26% to $3M (expense).

Employees:	992 as of Dec 31, 2023

Reporting Currency:	U.S. Dollars
Enterprise value:	$289.86M as of Dec 31, 2023
Annual revenue (TTM):	$274.42M as of Dec 31, 2023
EBITDA (TTM):	$24.58M as of Dec 31, 2023
Net annual income (TTM):	$28.52M as of Dec 31, 2023
Free cash flow (TTM):	$33.37M as of Dec 31, 2023
Net Debt Last Fiscal Year:	N/A
Shares outstanding:	23,759,462 as of Mar 13, 2024
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization